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Interaction between cannabis consumption and childhood abuse in psychotic disorders: 
preliminary findings on the role of different patterns of cannabis use  
 
Abstract  
Aim: Several studies have suggested that lifetime cannabis consumption and childhood abuse 
synergistically contribute to the risk for psychotic disorders. This study aimed to extend existing 
findings regarding an additive interaction between childhood abuse and lifetime cannabis use, by 
investigating the moderating role of type and frequency of cannabis use.  
Methods: 231 individuals presenting for the first time to mental health services with psychotic 
disorders and 214 unaffected population controls from South London, United Kingdom, were 
recruited as part of the Genetics and Psychosis study. Information about history of cannabis use was 
collected using the Cannabis Experiences Questionnaire. Childhood physical and sexual abuse were 
assessed using the Childhood Experience of Care and Abuse Questionnaire.  
Results: Neither lifetime cannabis use nor reported exposure to childhood abuse were associated 
with psychotic disorder when the other environmental variable was taken into account. Although 
the combination of the two risk factors raised the odds for psychosis by nearly three times (adjusted 
OR=2.94, 95% CI: 1.44-6.02, p=0.003), no evidence of interaction was found (adjusted OR=1.46, 
95% CI: -0.54-3.46, p=0.152). Furthermore, the association of high potency cannabis and daily 
consumption with psychosis was at least partially independent of the effect of childhood abuse. 
Conclusions: The heavy use of high potency cannabis increases the risk of psychosis but, in 
addition, smoking of traditional resin (hash) and less than daily cannabis use may increase the risk 
for psychosis when combined with exposure to severe childhood abuse. 
 
Key words: Cannabis; Childhood trauma; First-episode psychosis; Interaction; Marijuana smoking. 
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Introduction  
Both childhood maltreatment and cannabis abuse are considered to play a role in the pathogenesis 
of psychosis.
1,2
 Recent studies indicate that their effect on psychosis is neither fully confounded by 
other risk factors,
3,4
 nor a simple effect of gene–environment correlation.
5
 Moreover, there are 
suggestions that the risk for psychosis is greater in subjects exposed to both risk factors compared 
to those who experienced only either of them.
6-8
 For instance, a preliminary investigation using the 
US National Comorbidity Survey found that when cannabis use and sexual molestation/rape before 
16 years of age were entered into the same model neither of them was associated with psychosis, 
but it was only the combination of the two that increased the risk in a more than multiplicative way 
(OR=11.96, 95% CI 2.10-68.22).
6
  
Subsequent studies have confirmed the interaction between cannabis and trauma, though at 
an additive level. In a small sample of adolescents aged 12-15 years, the odds of reporting psychotic 
symptoms was 20.9 among subjects exposed to both child abuse and lifetime cannabis use, 
compared to 1.9 among those exposed only to cannabis, and 2.6 in those exposed only to trauma.
7
 
Konings and colleagues replicated this additive interaction in a birth cohort study (the Greek 
National Perinatal Study) and a longitudinal population study (the Netherlands Mental Health 
Survey and Incidence Study, NEMESIS). It was found that the strength of interaction between 
lifetime cannabis use and childhood trauma increased with the frequency of maltreatment 
suggesting a dose-dependent, extra-linear relationship.
8
 Contrasting with these promising findings, 
in another Dutch study (the Early Developmental Stage of Psychopathology, EDSP) there was no 
evidence that broadly defined traumatic experiences before 18 years of age (including, among 
others, wars, natural disasters, and serious accidents in addition to physical and sexual abuse) 
moderated the effect of smoking cannabis (five times or more) on psychotic symptoms.
9
 One 
possible reason for the discrepancies in the findings is that previous studies used fairly crude 
measures of cannabis use, which often did not consider frequency of consumption, and may have 
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4
included participants using different strengths of cannabis – higher concentrations of delta9-
tetrahydrocannabinol (∆9-THC) have been associated with greater odds of developing psychosis.
10
  
Therefore, the aim of the present study was to replicate existing findings regarding an 
additive interaction between childhood abuse and lifetime cannabis use in a sample of individuals 
presenting for the first time to mental health services with psychotic disorders and to extend these 
findings by investigating the moderating role of type and frequency of cannabis use on the 
association between childhood abuse and psychosis.  
 
Methods  
Participants 
Psychosis cases and unaffected controls were recruited as part of the Genetics and Psychosis Study 
(NIHR-BRC GAP), approved by the South London & Maudsley National Health Service (NHS) 
Trust and the Institute of Psychiatry ethical committees.
10,11
 All the participants were informed 
about the study aims and provided written informed consent. Cases were individuals aged 18 to 65 
with a first episode of psychosis who presented to the Lambeth, Southwark and Croydon adult in-
patient units of the South London and Maudsley Mental Health NHS Foundation Trust between 
December 2005 and October 2010. Cases had to fulfil International Classification of Diseases (ICD-
10)
12
 criteria for psychosis (codes F20-29 or F30-34); cases with a known organic cause for 
psychosis were excluded. Diagnoses were formulated by trained psychiatrists according to DSM-
IV
13
 and ICD 10
12
 criteria using the Operational Criteria system, OPCRIT
14
, on the basis of clinical 
notes collected for each patient during the first month after admission. Controls were recruited from 
the same catchment area as cases through leaflet distributions and internet and newspaper 
advertisements. Potential controls were screened for current or past psychotic disorders using the 
Psychosis Screening Questionnaire (PSQ),
15
 and those who met criteria for a psychotic disorder, or 
reported a previous diagnosis of psychosis, were excluded. Subjects with IQ<70 or poor English 
fluency were also excluded. 
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5
The data analysed in this paper was limited to the participants who provided full information 
about the two exposures of interest, by completing both the cannabis and the childhood abuse 
assessments. Therefore, it includes only 231/489 (47%) of the patients and 214/278 (77%) of the 
controls recruited into the study.
11
 Reasons for dropout included the lack of interest in the research, 
the length of the assessment, and their view of their mental health.
16,17
 There were no significant 
demographic differences between this subsample and the full GAP sample, except in the age of the 
control group (27.6 ± 9.0 vs. 30.2 ± 9.5, t=3.120, p=0.002), though this only differed on average by 
3 years.  
 
Measures 
Socio-demographic information (age, gender, self-rated ethnicity, level of education achieved) and 
family history of psychiatric disorder (psychotic disorders, mood disorders, or substance/alcohol 
use disorders) were collected on both cases and controls using respectively the Medical Research 
Council Sociodemographic Schedule
18
 and the Family Interview for Genetic Studies (FIGS).
19
 
Childhood physical and sexual abuse were assessed using the Childhood Experience of Care and 
Abuse Questionnaire (CECA.Q).
20
 In order to reduce the possibility of recall bias and maximise 
likely effect on psychosis, analyses were limited to physical abuse resulting in injuries and to 
penetrative sexual abuse reported as occurring prior to 17 years of age. Reports of either of these 
forms of severe abuse were considered to indicate exposure to childhood abuse. 
Lifetime cannabis use (i.e., having ever smoked cannabis, one time or more), type of 
cannabis most often used, and lifetime frequency of cannabis consumption (i.e., the frequency that 
characterized the subject’s most consistent pattern of use) were investigated using the Cannabis 
Experiences Questionnaire modified version (CEQmv).
10
 The types of cannabis used by the 
participants were classified as mainly resin (hash) vs. mainly sinsemilla (skunk), according to the 
different concentrations of delta9-tetrahydrocannabinol (∆9-THC). ∆9-THC is the active principle 
component responsible for the psychogenic effect and cognitive impairments associated with 
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6
cannabis,
21
 and is estimated as being 2–4% concentrated in cannabis resin but 12-18% in 
sinsemilla/skunk.
22
 The lifetime frequency of cannabis consumption was classified as less than 
daily vs. daily. 
 
Statistical analyses 
Analyses were carried out using Stata version 12.0 (Stata Corporation, USA). Logistic regression 
was used to assess the effect of the independent variables on the dependent variable (presence of 
psychotic disorder). Analyses were repeated adjusting for the potentially confounding effects of 
gender, self-rated ethnicity, current level of education, and family psychiatric history because in the 
study sample these variables were associated either with psychotic disorders or with either of the 
two exposures (lifetime cannabis use or childhood abuse). Statistical interaction is a model-
dependent estimation of biological synergism and refers to a situation in which the combined effect 
of two or more exposures exceeds the sum (additive model) or the product (multiplicative model) of 
their solitary effects.
23,24
 Additive interaction between cannabis use and childhood abuse was 
assessed using the Interaction Contrast Ratio (ICR), which estimates the relative excess due to 
interaction using odds ratios (OR) derived from logistic regressions. In the presence of statistical 
interaction, the ICR shows that the odds of being psychotic in those exposed to both risk factors is 
greater than the sum of the odds conveyed by each risk factor (departure from additivity).
25,26
 
Although the ICR was originally designed to assess additive interaction in cohort studies, it can be 
used in the context of case-control studies under the rare-disease assumption that, when the 
outcome is rare in the source population, odds ratios approximate risk ratios. Therefore, we 
stratified our independent variable into four levels: those exposed to both cannabis and child abuse 
(AB), those exposed only to cannabis (A), those exposed only to child abuse (B), and those exposed 
to neither cannabis nor child abuse (reference category). The Stata nlcom command was used to 
calculate the ICRs and the related 95% confidence intervals (CI) and p values.  
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7
One issue in interaction studies is that the “true” effect of the interaction may be confounded 
by correlation, meaning the extent to which one risk factor can drive the exposure to another risk 
factor.
27
 In this study Environment by Environment correlation (rEE) refers to the probability that 
childhood trauma per se alters the probability that an individual will use cannabis. To test rEE we 
analysed the effect of childhood trauma on cannabis use in the control group using logistic 
regression. Because of a small percentage of missing data concerning family psychiatric history, a 
sensitivity analysis was carried out to investigate the effect of missingness on the interaction 
between cannabis use and childhood abuse, using an imputation method. Post-hoc power analysis 
was conducted using GPower 3.1.5. 
 
Results  
Socio-demographic characteristics of the sample are reported in Table 1. There was some evidence 
of a difference between the psychosis cases and unaffected controls in terms of ethnicity, education 
level, and family psychiatric history. Furthermore, cases included a higher proportion of men 
although there was no strong evidence of a gender difference between the groups.  
[Insert Table 1 here] 
 
Cannabis use by childhood abuse interaction 
There was no evidence of an association between childhood abuse and cannabis use in the control 
group (OR=0.98, 95% CI 0.46-2.08, p=0.963), suggesting no evidence of environment-environment 
correlation. Table 2 presents unadjusted and adjusted ORs for the four combinations of the 
environmental exposures and their associations with psychotic disorder.  
[Insert Table 2 here] 
While lifetime cannabis use alone (i.e., in those without exposure to childhood abuse) and 
childhood abuse alone (i.e., in those with no lifetime cannabis use) were not associated with 
psychotic disorders, the combination of the two exposures raised the odds for the disease by nearly 
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8
three times (adj. OR=2.94, 95% CI 1.44-6.02, p=0.003). The ICR (2.18, 95% CI 0.01-4.36, 
p=0.049) was greater than 0 and showed some evidence of an effect, suggesting that the joint effect 
of cannabis use and childhood abuse on the additive scale was greater than the sum of their effects 
alone. However, after adjusting for confounders, the interaction effect was attenuated and became 
non-significant (ICR=1.46, 95% CI -0.54-3.46, p=0.152). 
 
Sensitivity analyses 
Family psychiatric history was the only variable to account for a small percentage of missingness in 
this sample (51/445, 11.5%). Missing data were equally distributed across levels of gender, 
education level, ethnicity, cannabis use, and child abuse but were more frequent in cases than 
controls (40 (17.3%) vs. 11 (5.1%), χ
2
=16.2, p<0.001). All missing values were replaced first by 
positive family history and then by negative family history and analyses were repeated using these 
new variables. There was no evidence of an interaction after imputation either of a positive 
(ICR=1.23, 95% CI -0.35-2.81, p=0.127) or negative (ICR=1.53, 95% CI -0.33-3.39, p=0.107) 
family history. 
 
Effect of type and frequency of cannabis use 
Associations with psychotic disorders for potency of cannabis consumed (hash-like vs. skunk-like) 
and frequency of cannabis use (daily vs. less than daily) in conjunction with reported exposure to 
childhood abuse are presented in Tables 3 and 4, respectively. Looking at the effect of cannabis 
alone or combined with childhood abuse (Tables 3 and 4), there is a suggestion that high-potency 
and daily cannabis users might develop psychotic disorders at least partially independently of the 
occurrence of severe childhood adversities. However, due to the small sample size, the interaction 
between childhood abuse and specific patterns of cannabis use could not be formally tested. 
[Insert Tables 3 & 4 here] 
 
Page 9 of 19 Early Intervention Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
9
Discussions  
Cannabis use by childhood abuse interaction 
This study found that neither lifetime cannabis use nor reported exposure to childhood abuse were 
associated with psychotic disorder when the other environmental variable was taken into account. 
By contrast, the combination of the two exposures appeared to exert a significantly greater effect 
than the sum of their individual effects suggesting an additive interaction. Nevertheless, after 
controlling for several covariates, this study found no evidence of interaction between lifetime 
cannabis use and childhood abuse. This result is consistent with the findings of Kuepper et al.,
9
 who 
reported that the effect of smoking cannabis on psychotic symptoms was not affected by exposure 
to traumatic events in childhood or adolescence. 
 
Effect of type and frequency of cannabis use 
To our knowledge, this is the first study to investigate the different effects of type and frequency of 
cannabis smoking in relation to the association between childhood abuse and psychosis. Our results 
suggest that hash-type cannabis and less than daily frequency of use are more likely to combine 
with childhood abuse in increasing the odds for psychosis. It could be speculated that the 
interaction between cannabis use and childhood abuse in psychosis is mostly driven by low 
potency and less than daily cannabis use. This might explain why our findings did not replicate 
the additive interaction described by Harley et al.
7
 and Konings et al.
8
 
On the other hand, high potency, skunk-like, cannabis and daily smoking seemed to 
influence the pathway to psychosis both alone as well as in association with childhood abuse in this 
sample. This confirms the existing literature demonstrating that individuals affected by psychotic 
disorders are over six times more likely to smoke cannabis every day and to use high-potency 
cannabis.
10,28,29
 Furthermore, previous studies have suggested that the effect of cannabis on 
psychosis was not confounded by childhood trauma.
28,29
 In fact, this is consistent with the view that 
in complex multifactorial disorders, such as psychotic disorders, individuals who are exposed to a 
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10
variety of risk factors might develop the disease either because of the specific effect of a particular 
risk factor (biological parallelism) or because of a combination of them (biological synergism).
23,30
 
 
Potential mechanisms  
According to the sensitization hypothesis, genetically vulnerable individuals exposed early to 
environmental risk factors – including childhood adversities and certain illicit drugs – might show a 
progressive increase in the dopaminergic response to psycho-social stress that, in turn, might result 
in stable changes in dopaminergic reactivity and the development of psychotic symptoms.
31,32
 
While preliminary animal studies have suggested that housing stress moderates rats’ response to 
delta-tetrahydrocannabinol (THC),
33
 recent evidence suggests that the sensitization process was 
bidirectional, so that environmental stress may affect sensitivity to THC but also that THC 
administration alters the endo-cannabinoid transmission.
34
 Despite these promising findings, the 
cross-sensitization between environmental stress and THC has not been fully supported by human 
studies.
35-37
 
 
Limitations  
Compared with previous studies that reported an additive interaction between cannabis and 
trauma,
7,8
 our findings are based on a smaller sample and might have been affected by inadequate 
power. In fact, post-hoc power analysis based on the results of the NEMESIS study
8
 suggests that 
we had over 95% power to replicate the difference in the prevalence of psychosis amongst cannabis 
consumers who were also exposed to child abuse (62.5% vs. 26.5%), but only 44% power to 
replicate the analogous difference in the unexposed group (9.2% vs. 4.8%). This could explain why 
our study resulted in weaker findings. To our knowledge, the only other study reporting trauma by 
cannabis interaction with a similar sample size (N=211) is the one by Harley et al.
7
: the authors 
reported an ICR of 17.4 which was suggestive of additive interaction, but the lack of confidence 
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11
intervals did not allow evaluation of the significance of their results. Thus, further studies of the 
interaction between cannabis and trauma are warranted.  
This study relied on self-reported retrospective information and, thus, results might have 
been affected by recall bias regarding traumatic experiences and use of illicit substances. Despite 
the fact that the reliability of psychosis patients’ reports of earlier abuse has been questioned in the 
past, a recent study demonstrated that such reports are stable over time, consistent between 
measures, and not affected by current symptomatology.
38
 In our sample the prevalence of either 
physical or sexual abuse among subjects affected by psychotic disorders was 28% which is higher 
than rates estimated for the general population
39
 but lower than those reported by literature reviews 
of prevalence rates in psychosis patients (50%).
40
 This might be related to the very conservative 
definition of physical and sexual abuse used in this study, the difficulty in disclosure some 
individuals experience during face-to-face interviews, or the tendency to under-report childhood 
abuse, especially when involving family members. Reassuringly, though, another first-episode 
psychosis sample obtained from an overlapping geographical area and using the same measurement 
tool – but a less conservative threshold – found almost identical rates of physical and sexual 
abuse (31%).
41
 Previous studies on cannabis by trauma interaction have used less conservative 
definitions of child abuse but still found elevated rates of psychotic phenomena in those 
reporting exposure to child abuse.
7,8
 As pointed out by several reviews,
40,42
 studies on 
childhood adversities and psychosis have employed a wide range of measures and definitions 
of early traumas, some of which did not account for severity. While broader definitions might 
be more sensitive to minor events and contribute to greater generalizability of results, use of 
narrow definitions of child abuse may be preferable as more severe events are postulated to 
be more accurately remembered thus reducing recall bias.
43
 Similarly to childhood abuse, 
cannabis use was assessed using a semi-structured interview, and was not supported by any 
biological measure such as a urine or blood test. However, given that we were interested in lifetime 
cannabis use and preferred type of cannabis used, these biological measures would not have 
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12
improved our study, because they are informative only about current consumption. Indeed, the 
strength of the association between cannabis and psychosis was consistent with those reported by 
existing literature reviews
2,3
 and the prevalence of lifetime cannabis consumption among cases and 
controls (69.7% vs. 57.9%) was fairly similar to the rates reported in a partially overlapping sample 
(62.5% vs. 56.9%).
10
 
Furthermore, it is possible that our findings were affected by selection bias, since our sample 
included only 231/489 (47%) of the patients and 214/278 (77%) of the controls recruited into the 
GAP study.
11
 This is because we included only participants who provided exhaustive information 
about both their frequency and type of cannabis use as well as the type and severity of childhood 
abuse. In addition, there was a small proportion of missing data in one of the covariates (family 
psychiatric history), an issue that was addressed by sensitivity analysis. However, our cases and 
controls appear similar to those included by Di Forti et al.
11
 in terms of the main demographic 
variables suggesting their representativeness of the full study sample. 
 
Conclusions 
This study did not replicate previous findings regarding the synergistic effect of cannabis 
consumption and childhood abuse on the onset of psychotic disorders. Our findings suggest that, 
besides the obvious risk conveyed by heavy use of high potency cannabis, smoking resin (hash) and 
less than daily smoking are likely to increase the odds for psychosis when combined with severe 
childhood abuse. For that reason, children and adolescents exposed to physical or sexual abuse 
might benefit from psycho-social interventions aimed at promoting adaptive coping strategies and 
informing them about the health-related risks of substance misuse. Clearly replication of these 
results is required before clinical trials to test this proposition could be initiated. 
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TABLE 1. Demographic characteristics for psychosis cases and unaffected controls 
 
 
 
Controls 
n (%) 
N=214 
Cases 
n (%) 
N=231 
Chi square/ 
Student’s t test 
p value 
 
Gender 
Male  
 
116 (54.2) 
 
146 (63.2) 
 
3.71 
 
0.054 
Ethnicity 
Non-Caucasian 
 
 
104 (48.6 ) 
 
 
153 (66.2) 
14.16 <0.001 
Level of education 
Lower than Degree  
 
111 (52.1) 
 
183 (79.9) 
38.29 <0.001 
Age mean (sd) 27.6 (9.0) 28.1 (9.1) -0.59 0.554 
Diagnosis 
Non-affective psychoses 
Affective psychoses 
  
140 (60.6) 
44 (19.0) 
  
 
 
 
Controls 
n (%) 
N=203 
Cases 
n (%) 
N=191 
 
 
 
 
 
Family psychiatric history 
 
75 (37.0) 92 (48.2) 
 
5.07 0.024 
sd, standard deviation. 
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TABLE 2. Cannabis use by childhood abuse interaction for psychotic disorders 
 
 
 
Controls 
n (%) 
N=214 
Cases 
n (%) 
N=231 
OR 95% CI 
(p value) 
Adj OR
†
 95% CI 
(p value) 
No child abuse and no 
cannabis use 
76 (35.5) 58 (25.1) 1  1  
Cannabis use without 
child abuse 
105 (49.1) 108 (46.8) 1.35 0.87-2.08 
(0.178) 
1.43 0.86-2.38 
(0.164) 
Child abuse without 
cannabis use 
14 (6.5) 12 (5.2) 1.12 0.48-2.61 
(0.787) 
1.05 0.40-2.74 
(0.919) 
Child abuse and  
cannabis use 
19 (8.9) 53 (22.9) 3.66 1.96-6.83 
(<0.001) 
2.94 
 
1.44-6.02 
(0.003) 
†
adjusted for gender, ethnicity, education level, and family psychiatric history. 
 Adj, adjusted. CI, confidence interval. OR, odds ratio. 
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TABLE 3. Cannabis potency by childhood abuse interaction for psychotic disorders 
 
 Hash-like cannabis Skunk-like cannabis 
 
 
Controls 
n (%) 
n=167 
Cases 
n (%) 
n=143 
OR 95% CI 
(p value) 
Adj 
OR
†
 
95% CI 
(p value) 
Controls 
n (%) 
n=137 
Cases 
n (%) 
n=158 
OR 95% CI 
(p value) 
Adj 
OR
†
 
95% CI 
(p value) 
No child abuse and 
no cannabis use 
76 (45.5) 58 (40.6) 1 - 1 - 76 (55.5) 58 (36.7) 1 - 1 - 
Child abuse without 
cannabis use 
 
14 (8.4) 12 (8.4) 1.12 0.48- 
2.61 
(0.787) 
0.96 0.37- 2.51 
(0.938) 
14 (10.2) 12 (7.6) 1.12 0.48- 2.61 
(0.787) 
1.15 0.44- 3.04 
(0.776) 
Cannabis use 
without child abuse 
 
68 (40.7) 48 (33.6) 0.92 0.56- 
1.53 
(0.761) 
1.04 0.57- 1.88 
(0.908) 
37 (27.0) 60 (38.0) 2.12 1.25- 3.62 
(0.006) 
2.16 1.15- 4.06 
(0.016) 
Cannabis use and 
child abuse 
9 (5.4) 25 (17.5) 3.64 1.58- 
8.39 
(0.002) 
 
2.82 1.12- 7.11 
(0.028) 
10 (7.3) 28 (17.7) 3.67 1.65- 8.16 
(0.001) 
3.46 1.34- 8.97 
(0.011) 
 
†
adjusted for gender, ethnicity, education level, and family psychiatric history. 
Adj, adjusted. CI, confidence interval. OR, odds ratio. 
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TABLE 4. Frequency of cannabis use by childhood abuse interaction for psychotic disorders 
 
 Less than daily use Daily use 
 
 
Controls 
n (%) 
n=197 
Cases 
n (%) 
n=166 
OR 95% CI 
(p value) 
Adj 
OR
†
  
95% CI 
(p value) 
Controls 
n (%) 
n=107 
Cases 
n (%) 
n=135 
OR 95% CI 
(p value) 
 
Adj 
OR
†
 
95% CI 
(p value) 
No child abuse and 
no cannabis use 
76 (38.6) 58 
(34.9) 
1  1  76 (71.0) 58 
(43.0) 
1  1  
Child abuse 
without cannabis 
use 
 
14 (7.1) 12 (7.2) 1.12 0.48- 2.61 
(0.787) 
0.97 0.37- 2.52 
(0.944) 
14 (13.1) 12 (8.9) 1.12 0.48- 
2.61 
(0.787) 
1.19 0.45- 3.16 
(0.732) 
Cannabis use 
without child abuse 
 
92  
(46.7) 
59 
(35.5) 
0.84 0.52- 1.35 
(0.471) 
0.97 0.56- 1.68 
(0.919) 
13 (12.2) 49 
(36.3) 
4.94 2.45- 
9.95 
(<0.001) 
5.37 2.33- 12.34 
(<0.001) 
Cannabis use and 
child abuse 
 
15 (7.6) 37 
(22.3) 
3.23 1.62- 6.45 
(0.001) 
 
2.51 1.13- 5.56 
(0.023) 
4 (3.7) 16 
(11.9) 
5.24 1.66- 
16.52 
(0.005) 
5.31 1.45- 19.47 
(0.012) 
 
†
adjusted for gender, ethnicity, education level, and family psychiatric history. 
Adj, adjusted. CI, confidence interval. OR, odds ratio. 
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